CONTINUOUS peripheral nerve block (CPNB) techniques continue to be increasingly used. CPNB catheter infection is an issue that has received little attention to date. The frequency of infection associated with peripheral nerve catheters remains poorly defined.1–4Although the risk of infection during CPNB is a major issue, the published literature has mainly focused on the conflicting evidence of the frequency of infectious complications associated with epidural anesthesia. Recent studies show that between 23 and 57% of peripheral nerve catheters may become colonized, with 0–3% resulting in localized infection.1–10Severe infectious complications recently reported in the literature include psoas abscess complicating continuous femoral nerve blocks,1,11axillary abscess and necrotizing fasciitis5,12after continuous and single shot axillary nerve blocks, and thigh and interscalene abscesses after continuous popliteal sciatic and interscalene nerve blocks, respectively6,13(table 1). An exogenous source of contamination is frequently suspected. The most frequently detected microorganism on the skin surface and in colonized catheter is Staphylococcus epidermidis ,1–4whereas Staphylococcus aureus  is mainly reported in infections or abscess formation.1,2,5,11,13Several risk factors, including appropriate patient selection (intensive care unit or trauma patients),1,2catheter site insertion,1–3prophylactic antibiotic use,1,2,5local anesthetic solution contamination, and catheter duration,1,2have been suspected to modify the risk of infection related to CPNB. The current recommendations to control infectious complications associated with CPNB are based on existing literature and guidelines for the prevention of epidural or intravascular catheter-related infection. The American Society for Regional Anesthesia and Pain Medicine guidelines on this topic have been published in Regional Anesthesia and Pain Medicine.14These recommendations highlighted the importance of asepsis during regional anesthesia needle and catheter insertion, including handwashing, use of protective barriers (mask, gloves, gowns, and drapes), and skin disinfectants. The role of subcutaneous tunneling and of bacterial filters is still controversial.14Guidelines for practice improvement must be built according to specific actual risk applied to each procedure and certainly cannot be extrapolated without some restrictions.15CPNBs are increasing in popularity, and the incidence of infection associated with CPNB is thankfully rare. However, infectious complications will become undoubtedly more common. This review is to tell the reader what is actually known about risk factors specific to CPNBs.

Figure. No caption available

Figure. No caption available

Close modal

The incidence of inflammation and infection associated with CPNB is low. Exogenous pathogens are suspected as the most likely sources of infection. The skin area surrounding the perineural catheter insertion site is the reported origin of the greater majority of colonizing microorganisms.1–4,16The predominance of coagulase-negative Staphylococcus  at the perineural catheter tip is not surprising. This represents colonization of the skin at the catheter insertion site and the subsequent contamination of the catheter on removal despite aseptic conditions.1This hypothesis is supported in the study by Capdevila et al .,1who showed that 44% of the catheters were colonized if signs of local inflammation were present versus  19% when no evidence of inflammation existed. Some authors14,16suggest that S. aureus  is more resistant to nonalcoholic disinfectants than other bacteria and that hair follicles and the orifices of sebaceous glands protect the organism as a result of the lipid covering of the stratum corneum. The American Society of Regional Anesthesia and Pain Medicine recommends the routine use of antiseptic solutions with an alcohol base for skin disinfection before peripheral regional techniques due to their penetration of the stratum corneum and their rapid and prolonged effect.14 

There is a great variability in the rate of inflammation and infection across studies (table 2). A careful analysis for the reasons for these differences and of the procedures to minimize infection in the low versus  high infection rates should be done. Recent studies1,2,4report that independent risk factors were associated with catheter colonization and related infection.

Figure. No caption available

Figure. No caption available

Close modal

A strong risk factor for development of infectious adverse events during CPNB is a stay in the intensive care unit (ICU). In the ICU, most of the patients studied had sustained major trauma. It has been suggested that trauma ICU patients have a greater number of skin bacterial species than other patients and that inadequate and difficult working conditions and environment prevent a total aseptic technique during catheter insertion.2Moreover, compromised cellular immunity, which frequently develops in the ICU patients, may contribute to the higher risk of infection. Neuburger et al .2claimed that the high incidence of local inflammation and infection observed in their study is explained by large number of trauma patients (30%). However, in Capdevila et al . study,1the stay in ICU is an independent risk factor for local inflammation. This factor is independent from the group of trauma patients. All the catheters in that study were put in before ICU admission in surgical and trauma patients. Anesthesiologists should be aware of the increased risk of catheter-related infection in the subgroup of ICU patients.

Duration of catheter also seems to be an important risk factor of local infectious problems. Capdevila et al .1reported that CPNB of duration longer than 48 h was an independent risk factor for local inflammation and catheter-related local infection (odds ratio [95% CI], 4.61 [1.57–15.9]). Capdevila et al .1noted 3% of local inflammation defined by focal pain, redness, and induration, and only one case of systemic infection (psoas muscle abscess). We analyzed the incidences of local inflammation for each period of time in the 1416 patients of Capdevila’s study and report them in table 3. Interestingly the incidence of inflammation increased significantly for each studied period, except for the 24-h selected threshold. The longer that the CPNB catheter is still in place, the more the risk of local inflammation is important. In the same study, we calculated the adjusted odds ratio for local inflammation and signs of infection as a function of every 24-h time period. The results are reported in figure 1. After the 48-h period, if we consider odds ratio, the risk of local inflammation and/or infection signs increases for each time period considered. Similarly, Neuburger et al .2observed a relation between the mean duration of catheter use 5 (range, 2–18) days and the patients having an infection requiring surgical drainage. Noninfected patients had a mean catheter use duration of 4 (range, 1–36) days.

Figure. No caption available

Figure. No caption available

Close modal

Fig. 1. Odds ratio for local inflammation and/or signs of infection as a function of every 24-h time period for all the continuous peripheral nerve block catheters. From Capdevila  et al. 1 

Fig. 1. Odds ratio for local inflammation and/or signs of infection as a function of every 24-h time period for all the continuous peripheral nerve block catheters. From Capdevila  et al. 1 

Close modal

The absence of antibiotic prophylaxis was noted to be an independent risk factor for local inflammation.1,2,5In a series of 405 continuous axillary blocks, the only abscess occurred in a patient who had not received antibiotics.5That patient was scheduled in a rehabilitation program after a chronic pain syndrome. Eighteen patients did not receive the usual 2 days of antibiotic therapy. Morin et al .4reported that the use of an antibiotic in the postoperative period can limit the risk of local infection. However it appears that a single dose of antibiotics injected 30 to 60 min after catheter insertion probably does not provide sufficient protection.5 

The site of catheter insertion can be another potential risk factor for bacterial colonization. The femoral or axillary sites are associated with a rate of catheter bacterial colonization as high as 37% to 57%,1,3whereas the popliteal catheter has a reduced colonization rate of between 0% to 19%.1,4,17This finding may be related to the density of sebaceous glands in the groin or the axilla, which has been shown to affect the ability of disinfection to decrease the percentage of microrganisms.16We analyzed the incidence of local inflammation for CPNBs at the most common sites of placement as a function of every 24-h time period in the Capdevila et al . study.1The results are reported in figure 2. As for the catheter colonization, the incidence of local inflammation is related to the duration of the catheter and to the location. The femoral/fascia iliaca compartment and axillary continuous blocks are associated with the higher rate of patients’ local inflammation. Morin et al .4highlighted the fact that catheter placement in the groin can increase the risk of a local inflammation. The authors reported an odd ratio at 3.4 (1.5–7.8) for this parameter in comparison with other catheter locations.

Fig. 2. Incidences of local inflammation as a function of every 24-h time period at four selected sites of continuous peripheral nerve block catheters. The incidences increase if we consider axillary and femoral/fascia iliaca compartment (FIC) locations. From Capdevila  et al. 1 SN = sciatic nerve. 

Fig. 2. Incidences of local inflammation as a function of every 24-h time period at four selected sites of continuous peripheral nerve block catheters. The incidences increase if we consider axillary and femoral/fascia iliaca compartment (FIC) locations. From Capdevila  et al. 1 SN = sciatic nerve. 

Close modal

Male sex seems significantly associated with an increased risk of local inflammation.1In studies by Capdevila et al .1and Morin et al .,4age, underlying disease (diabetes mellitus, cancer, infectious disease, steroid therapy), and technically difficult catheter insertion were not associated with an increased risk of local inflammation or infection. However, these statements were not clearly supported by power analysis.

In the majority of studies investigating the infectious risk of CPNB, the anesthesiologists have worn a hat, surgical mask, gloves and gown and have prepared the skin with disinfectants and sterile drapes. This fact probably partially explains the very low incidence of infection during CPNB.

Table 4describes the risk factors for peripheral nerve block catheter inflammation based on clear evidence in the literature, unproved factors, and those that are proven not to be a risk factor.

Figure. No caption available

Figure. No caption available

Close modal

Studies show that both equipment and local anesthetic solutions can become contaminated.18 

Rituals and myths regarding aseptic technique performed by anesthesiologists abound in the operating room. Woodhead et al .18reported that only 12% of physicians based infection control practice in the operating room on evidence-based medicine data.

There is good evidence that the risk of central venous catheter infection is reduced by the use of a technique involving surgical type aseptic conditions compared with hand washing and sterile gloves alone.19,20Therefore, this method should be applied to CPNB techniques.

The American Society for Regional Anesthesia and Pain Medicine recommendations14discuss hand cleansing, jewelry, gloves, gowns, masks, bacterial filter, antiseptic prep solutions and methods of applying them, and drapes or dressings at the catheters sites. They are reported in table 5. These are generic recommendations regarding single shot and continuous regional anesthetic techniques, and the authors commented that little is known regarding CPNBs. However, it seems reasonable to apply these recommendations to CPNB techniques.

Figure. No caption available

Figure. No caption available

Close modal

Other specific parameters like catheter tunneling, specific dressing, and infusate contamination can be discussed separately. The dressing around a CPNB catheter minimizes the risk of premature displacement and allows inspection of the catheter skin entry point (local inflammation) if transparent. Visible local inflammation, even without pus, is associated with an increase in catheter colonization.1,2However, we have seen that high catheter colonization rates are not related to deep infection or abscesses.1–3In contrast, the absence of skin inflammation does not mean that there is no bacterial catheter colonization. The transparent dressing is impermeable, resulting in the underlying skin becoming moist and allowing the growth of organisms. On the other hand, a totally porous dressing can maximize the site access to bacteria. Another way of decreasing skin colonization is to place antiseptic around the puncture site or to use antiseptic dressings. The rationale of this practice is to prevent the regeneration of skin microorganisms in the hours after the initial antiseptic application. Iodine-based powders or creams can be used, but they tend to reduce dressing adhesion. Catheter tunneling has the theoretical advantage of decreased catheter movement and decreased spread of infection. There are several techniques for tunneling CPNB catheters using 17- to 18-gauge tuohy or 18-gauge IV needles with or without a plastic cannula.21,22Borgeat et al .6,21used a lateral modified approach for continuous interscalene blocks and tunneled the interscalene catheter. They reported no catheter dislodgement in 700 patients and 1% of patients with signs and symptoms of local infection. Capdevila et al .1in 1416 CPNB did not tunnel the catheters and reported 11% of catheter accidental withdrawal and 3% of local inflammation signs. A recent study in 402 patients with CPNBs highlighted the interest of catheter tunneling.23The authors reported a colonization incidence of 6.22% (3.8–8.5%), with a microbiologic analysis of the catheter tip cultures revealing coagulase negative Staphylococcus  in 72%. Therefore, it appears that subcutaneous tunneling seems beneficial in reducing clinically relevant movements of the catheters and perhaps in providing an extra benefit regarding the development of CPNB catheter site colonization. The infusate can be the source of infection, although it is thought to be the least important because the solutions of local anesthetics have some antibacterial activity.24The risks of infusate contamination may increase with frequent changes of the catheter hub, with syringes repeatedly changed in surgical ward by nurses without masks, hats, and gloves and in long-term continuous regional blocks.18Kirschke et al .25reported S. aureus  joint and soft-tissue infections occurring in outpatients after therapeutic intraarticular injections. In 17 patients, 3 were subsequently hospitalized for infections. All of these patients received triamcinolone-lidocaine solutions. The multiple-dose vial of lidocaine was contaminated with S. aureus . It seems reasonable to use large volume bags of regional block infusate prepared by the pharmacy or reputable supplier/industrial firm and to be aware of the infusate preparation conditions in the operating theaters, postanesthetic care units, or surgical wards.

Risk factors are perfectly demonstrated to be related to local inflammation or infection during CPNB techniques. There are duration of the continuous infusion more than 48 h, the absence of antibiotic prophylaxy, the stay in ICU for a patient, and axillary or femoral location of the catheter. The coagulase-negative Staphylococcus  is predominantly noted at the perineural catheter tip. Although definitive proof is lacking, there is strong evidence that the maximal sterile precautions used for epidural insertion can be recommended to anesthesiologists for CPNB. The American Society of Regional Anesthesia recommendations are based on clinical evidence for some and theoretical rationale for others. Caregivers should be aware of risk factors for inflammation and possibly for infection with CPNB.

1.
Capdevila X, Pirat P, Bringuier S, Gaertner E, Singelyn F, Bernard N, Choquet O, Bouaziz H, Bonnet F: French Study Group on Continuous Peripheral Nerve Blocks. Continuous peripheral nerve blocks in hospital wards after orthopedic surgery: a multicenter prospective analysis of the quality of postoperative analgesia and complications in 1,416 patients. Anesthesiology 2005; 103:1035–45
2.
Neuburger M, Buttner J, Blumenthal S, Breitbarth J, Borgeat A: Inflammation and infection complications of 2285 perineural catheters: a prospective study. Acta Anaesthesiol Scand 2007; 51:108–14
3.
Cuvillon P, Ripart J, Lalourcey L, Veyrat E, L’Hermite J, Boisson C, Thouabtia E, Eledjam JJ: The continuous femoral nerve block catheter for postoperative analgesia: bacterial colonization, infectious rate and adverse effects. Anesth Analg 2001; 93:1045–9
4.
Morin AM, Kerwat KM, Klotz M, Niestolik R, Ruf VE, Wulf H, Zimmermann S, Eberhart LH: Risk factors for bacterial catheter colonization in regional anaesthesia. BMC Anesthesiol 2005; 5:1
5.
Bergman BD, Hebl JR, Kent J, Horlocker TT: Neurologic complications of 405 consecutive continuous axillary catheters. Anesth Analg 2003; 96:247–52
6.
Borgeat A, Dullenkopf A, Ekatodramis G, Nagy L: Evaluation of the lateral modified approach for continuous interscalene block after shoulder surgery. Anesthesiology 2003; 99:436–42
7.
Stojadinovic A, Auton A, Peoples GE, McKnight GM, Shields C, Croll SM, Bleckner LL, Winkley J, Maniscalco-Theberge ME, Buckenmaier CC 3rd: Responding to challenges in modern combat casualty care: innovative use of advanced regional anesthesia. Pain Med 2006; 7:330–8
8.
Meier G, Bauereis C, Heinrich C: Interscalene brachial plexus catheter for anesthesia and postoperative pain therapy. Experience with a modified technique Anaesthesist 1997; 46:715–9
9.
Neuburger M, Breitbarth J, Reisig F, Lang D, Buttner J. Complications and adverse events in continuous peripheral regional anesthesia Results of investigations on 3,491 catheters Anaesthesist. 2006; 55:33–40
10.
Swenson JD, Bay N, Loose E, Bankhead B, Davis J, Beals TC, Bryan NA, Burks RT, Greis PE: Outpatient management of continuous peripheral nerve catheters placed using ultrasound guidance: an experience in 620 patients. Anesth Analg 2006; 103:1436–43
11.
Adam F, Jaziri S, Chauvin M: Psoas abscess complicating femoral nerve block catheter. Anesthesiology 2003; 99:230–1
12.
Nseir S, Pronnier P, Soubrier S, Onimus T, Saulnier F, Mathieu D, Durocher A: Fatal streptococcal necrotizing fasciitis as a complication of axillary brachial plexus block. Br J Anaesth 2004; 92:427–9
13.
Compere V, Cornet C, Fourdrinier V, Maitre AM, Mazirt N, Biga N, Dureuil B: Thigh abscess as a complication of continuous popliteal sciatic nerve block. Br J Anaesth 2005; 95:255–6
14.
Hebl JR: The importance and implications of aseptic techniques during regional anesthesia. Reg Anesth Pain Med 2006; 31:311–23
15.
Amalberti R, Auroy Y, Berwick D, Barach P: Five system barriers to achieving ultrasafe health care. Ann Intern Med 225;142: 756–64
16.
Sato S, Sakuragi T, Dan K: Human skin flora as a potential source of epidural abscess. Anesthesiology 1996; 85:1276–82
17.
Borgeat A, Blumenthal S, Lambert M, Theodorou P, Vienne P: The feasibility and complications of the continuous popliteal nerve block: a 1001-case survey. Anesth Analg 2006; 103:229–33
18.
Woodhead K, Taylor EW, Bannister G, Chesworth T, Hoffman P, Humphreys H: Behaviours and rituals in the operating theatre. A report from the Hospital Infection Society Working Party on Infection Control in Operating Theatres. J Hosp Infect 2002; 51:241–55
19.
Raad II, Hanna HA: Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med 2002. 22; 162:871–8
20.
O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA: Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51(RR-10):1–29
21.
Ekatodramis G, Borgeat A: Subcutaneous tunneling of the interscalene catheter. Can J Anaesth 2000; 47:716–7
22.
Boezaart AP, de Beer JF, du Toit C, van Rooyen K: A new technique of continuous interscalene nerve block. Can J Anaesth 1999; 46:275–81
23.
Legrand JF, Compere V, Guitard PG, Ouennich A, Frébourg N, Dureuil B: Bacterial colonization after tunneling in 402 perineural catheters:a prospective study. (In French) Ann Fr Anesth Réanim 2007; S65–7
24.
Feldman JM, Chapin-Robertson K, Turner J: Do agents used for epidural analgesia have antimicrobial properties? Reg Anesth 1994; 19:43–7
25.
Kirschke DL, Jones TF, Stratton CW, Barnett JA, Schaffner W: Outbreak of joint and soft-tissue infections associated with injections from a multiple-dose medication vial. Clin Infect Dis 2003; 36:1369–73
26.
Wiegel M, Gottschaldt U, Hennebach R, Hirschberg T, Reske A: Complications and adverse effects associated with continuous peripheral nerve blocks in orthopedic patients. Anesth Analg 2007; 104:1578–82